CLINICAL_TRIALS
trial_result
· 2015-07-14
Clinical Trial Update: A Study of Abicipar Pegol in Patients With Diabetic Macular Edema [Phase 2]
Summary
A Phase 2 trial evaluating Abicipar Pegol for diabetic macular edema has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Macular Edema | Phase 2 | Status: COMPLETED